vs
CrossAmerica Partners LP（CAPL）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
CrossAmerica Partners LP的季度营收约是Royalty Pharma plc的1.4倍（$866.3M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 1.2%，领先33.3%），Royalty Pharma plc同比增速更快（4.8% vs -8.3%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -4.1%）
塔峰资本合伙人（TowerBrook Capital Partners）是一家总部位于伦敦和纽约的投资管理公司，2005年从索罗斯基金管理分拆独立。该机构主打私募股权及结构性机会投资，曾收购奢侈品品牌Jimmy Choo控股权，截至2025年其管理规模超250亿美元，官网公示在管投资项目共110个。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
CAPL vs RPRX — 直观对比
营收规模更大
CAPL
是对方的1.4倍
$622.0M
营收增速更快
RPRX
高出13.0%
-8.3%
净利率更高
RPRX
高出33.3%
1.2%
两年增速更快
RPRX
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $866.3M | $622.0M |
| 净利润 | $10.2M | $214.2M |
| 毛利率 | 12.4% | — |
| 营业利润率 | 3.0% | 62.4% |
| 净利率 | 1.2% | 34.4% |
| 营收同比 | -8.3% | 4.8% |
| 净利润同比 | -39.6% | 2.9% |
| 每股收益（稀释后） | $0.24 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPLRPRX
| Q4 25 | $866.3M | $622.0M | ||
| Q3 25 | $971.8M | $609.3M | ||
| Q2 25 | $961.9M | $578.7M | ||
| Q1 25 | $862.5M | $568.2M | ||
| Q4 24 | $944.2M | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $941.5M | $568.0M |
净利润CAPLRPRX
| Q4 25 | $10.2M | $214.2M | ||
| Q3 25 | $13.6M | $288.2M | ||
| Q2 25 | $25.2M | $30.2M | ||
| Q1 25 | $-7.1M | $238.3M | ||
| Q4 24 | $16.9M | $208.2M | ||
| Q3 24 | $10.7M | $544.0M | ||
| Q2 24 | $12.4M | $102.0M | ||
| Q1 24 | $-17.5M | $4.8M |
毛利率CAPLRPRX
| Q4 25 | 12.4% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 10.5% | — | ||
| Q1 25 | 10.4% | — | ||
| Q4 24 | 10.7% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 9.2% | — | ||
| Q1 24 | 8.6% | — |
营业利润率CAPLRPRX
| Q4 25 | 3.0% | 62.4% | ||
| Q3 25 | 2.9% | 70.1% | ||
| Q2 25 | 4.3% | 36.3% | ||
| Q1 25 | 0.2% | 94.0% | ||
| Q4 24 | 3.0% | 60.9% | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.5% | 50.2% | ||
| Q1 24 | -1.4% | -13.0% |
净利率CAPLRPRX
| Q4 25 | 1.2% | 34.4% | ||
| Q3 25 | 1.4% | 47.3% | ||
| Q2 25 | 2.6% | 5.2% | ||
| Q1 25 | -0.8% | 41.9% | ||
| Q4 24 | 1.8% | 35.1% | ||
| Q3 24 | 1.0% | 96.3% | ||
| Q2 24 | 1.1% | 19.0% | ||
| Q1 24 | -1.9% | 0.8% |
每股收益（稀释后）CAPLRPRX
| Q4 25 | $0.24 | $0.49 | ||
| Q3 25 | $0.34 | $0.67 | ||
| Q2 25 | $0.64 | $0.07 | ||
| Q1 25 | $-0.20 | $0.55 | ||
| Q4 24 | $0.42 | $0.46 | ||
| Q3 24 | $0.27 | $1.21 | ||
| Q2 24 | $0.31 | $0.23 | ||
| Q1 24 | $-0.48 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.1M | $618.7M |
| 总债务越低越好 | $687.2M | $9.0B |
| 股东权益账面价值 | — | $9.7B |
| 总资产 | $964.7M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资CAPLRPRX
| Q4 25 | $3.1M | $618.7M | ||
| Q3 25 | $5.8M | $938.9M | ||
| Q2 25 | $9.7M | $631.9M | ||
| Q1 25 | $6.7M | $1.1B | ||
| Q4 24 | $3.4M | $929.0M | ||
| Q3 24 | $7.8M | $950.1M | ||
| Q2 24 | $5.5M | $1.8B | ||
| Q1 24 | $6.3M | $843.0M |
总债务CAPLRPRX
| Q4 25 | $687.2M | $9.0B | ||
| Q3 25 | $700.8M | $8.9B | ||
| Q2 25 | $722.7M | $8.0B | ||
| Q1 25 | $774.1M | $7.6B | ||
| Q4 24 | $763.9M | $7.6B | ||
| Q3 24 | $769.2M | $7.6B | ||
| Q2 24 | $786.7M | $7.6B | ||
| Q1 24 | $795.8M | $6.1B |
股东权益CAPLRPRX
| Q4 25 | — | $9.7B | ||
| Q3 25 | — | $9.6B | ||
| Q2 25 | — | $9.5B | ||
| Q1 25 | — | $9.8B | ||
| Q4 24 | — | $10.3B | ||
| Q3 24 | — | $10.3B | ||
| Q2 24 | — | $9.8B | ||
| Q1 24 | — | $9.9B |
总资产CAPLRPRX
| Q4 25 | $964.7M | $19.6B | ||
| Q3 25 | $998.9M | $19.3B | ||
| Q2 25 | $1.0B | $18.3B | ||
| Q1 25 | $1.1B | $17.6B | ||
| Q4 24 | $1.1B | $18.2B | ||
| Q3 24 | $1.1B | $18.0B | ||
| Q2 24 | $1.2B | $17.7B | ||
| Q1 24 | $1.2B | $16.1B |
负债/权益比CAPLRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $29.4M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $22.4M | — |
| 自由现金流率自由现金流/营收 | 2.6% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 2.89× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $55.8M | — |
8季度趋势，按日历期对齐
经营现金流CAPLRPRX
| Q4 25 | $29.4M | $827.1M | ||
| Q3 25 | $24.4M | $702.6M | ||
| Q2 25 | $22.6M | $364.0M | ||
| Q1 25 | $15.0M | $596.1M | ||
| Q4 24 | $11.1M | $742.5M | ||
| Q3 24 | $41.9M | $703.6M | ||
| Q2 24 | $28.9M | $658.2M | ||
| Q1 24 | $5.8M | $664.6M |
自由现金流CAPLRPRX
| Q4 25 | $22.4M | — | ||
| Q3 25 | $17.7M | — | ||
| Q2 25 | $10.8M | — | ||
| Q1 25 | $4.9M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $34.2M | — | ||
| Q2 24 | $23.6M | — | ||
| Q1 24 | $-289.0K | — |
自由现金流率CAPLRPRX
| Q4 25 | 2.6% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 3.2% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -0.0% | — |
资本支出强度CAPLRPRX
| Q4 25 | 0.8% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.6% | — |
现金转化率CAPLRPRX
| Q4 25 | 2.89× | 3.86× | ||
| Q3 25 | 1.79× | 2.44× | ||
| Q2 25 | 0.90× | 12.06× | ||
| Q1 25 | — | 2.50× | ||
| Q4 24 | 0.66× | 3.57× | ||
| Q3 24 | 3.92× | 1.29× | ||
| Q2 24 | 2.33× | 6.45× | ||
| Q1 24 | — | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPL
| Retail Segment | $505.3M | 58% |
| Wholesale | $360.9M | 42% |
| Other | $1.2M | 0% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
